Mingyan Zhou

3.1k total citations
57 papers, 2.5k citations indexed

About

Mingyan Zhou is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Mingyan Zhou has authored 57 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Epidemiology. Recurrent topics in Mingyan Zhou's work include Drug Transport and Resistance Mechanisms (8 papers), Adipose Tissue and Metabolism (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Mingyan Zhou is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Adipose Tissue and Metabolism (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Mingyan Zhou collaborates with scholars based in United States, China and Hong Kong. Mingyan Zhou's co-authors include Joanne Wang, Karen Engel, Xia Li, Karen S.L. Lam, Aimin Xu, Yu Wang, Joanne Wang, Georges Belfort, James E. Kilduff and Guangliang Chen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Mingyan Zhou

54 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingyan Zhou United States 30 861 440 436 411 217 57 2.5k
Xiaojiang Xu United States 31 1.2k 1.4× 587 1.3× 179 0.4× 209 0.5× 149 0.7× 76 2.9k
Jin Zhou China 32 1.2k 1.4× 98 0.2× 967 2.2× 471 1.1× 493 2.3× 76 3.0k
Lei Cao China 30 800 0.9× 304 0.7× 216 0.5× 299 0.7× 95 0.4× 104 2.6k
Xuesong Chen China 35 1.6k 1.9× 535 1.2× 338 0.8× 502 1.2× 121 0.6× 193 3.8k
Suresh C. Tyagi United States 37 1.7k 2.0× 315 0.7× 243 0.6× 574 1.4× 175 0.8× 129 3.9k
Natalia de las Heras Spain 30 1.1k 1.3× 360 0.8× 282 0.6× 464 1.1× 478 2.2× 107 3.2k
Lin Gao China 36 1.8k 2.1× 317 0.7× 299 0.7× 234 0.6× 145 0.7× 140 3.5k
James A. Thliveris Canada 32 963 1.1× 310 0.7× 322 0.7× 217 0.5× 187 0.9× 122 2.8k
Qian Zhang China 35 2.4k 2.8× 259 0.6× 370 0.8× 302 0.7× 158 0.7× 231 4.2k
Chao Liu China 31 1.5k 1.7× 280 0.6× 620 1.4× 228 0.6× 65 0.3× 121 2.8k

Countries citing papers authored by Mingyan Zhou

Since Specialization
Citations

This map shows the geographic impact of Mingyan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyan Zhou more than expected).

Fields of papers citing papers by Mingyan Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingyan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyan Zhou. The network helps show where Mingyan Zhou may publish in the future.

Co-authorship network of co-authors of Mingyan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Mingyan Zhou. A scholar is included among the top collaborators of Mingyan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingyan Zhou. Mingyan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Mingyan, et al.. (2025). Strongly coupled relative humidity sensor coated with graphene oxide/polyvinyl alcohol composite. Emerging Materials Research. 14(2). 208–215.
3.
Beretta, Martina, et al.. (2024). Complete inhibition of liver acetyl-CoA carboxylase activity is required to exacerbate liver tumorigenesis in mice treated with diethylnitrosamine. SHILAP Revista de lepidopterología. 12(1). 2 indexed citations
4.
Zhou, Mingyan, Catherine Li, Frances L. Byrne, et al.. (2024). Beneficial effects of MGL‐3196 and BAM15 combination in a mouse model of fatty liver disease. Acta Physiologica. 240(10). e14217–e14217. 3 indexed citations
5.
Olzomer, Ellen M., Mingyan Zhou, Martina Beretta, et al.. (2024). Beneficial effects of simultaneously targeting calorie intake and calorie efficiency in diet-induced obese mice. Clinical Science. 138(4). 173–187. 5 indexed citations
6.
Li, Xiaoliang, Mingyan Zhou, Jiangbo Sun, et al.. (2024). Integrating network pharmacology, bioinformatics, and experimental validation to unveil the molecular targets and mechanisms of galangin for treating hepatocellular carcinoma. BMC Complementary Medicine and Therapies. 24(1). 208–208. 6 indexed citations
8.
Sun, Yixin, et al.. (2023). Afzelin protects against doxorubicin-induced cardiotoxicity by promoting the AMPKα/SIRT1 signaling pathway. Toxicology and Applied Pharmacology. 477. 116687–116687. 1 indexed citations
9.
Zhang, Xuguang, Aixia Liu, Yuxin Zhang, et al.. (2022). A diarylheptanoid compound from Alpinia officinarum Hance ameliorates high glucose-induced insulin resistance by regulating PI3K/AKT-Nrf2-GSK3β signaling pathways in HepG2 cells. Journal of Ethnopharmacology. 295. 115397–115397. 31 indexed citations
10.
Fernández, Michael, et al.. (2018). A Computational Assessment of the Robustness of Cancer Treatments with Respect to Immune Response Strength, Tumor Size and Resistance. 7(1). 1–26. 6 indexed citations
11.
Tian, Yuan, Vincent Wai‐Sun Wong, Grace Lai–Hung Wong, et al.. (2015). Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma. Cancer Research. 75(22). 4803–4816. 110 indexed citations
12.
Zhou, Mingyan, Aimin Xu, Paul Kwong Hang Tam, et al.. (2012). Upregulation of UCP2 by Adiponectin: The Involvement of Mitochondrial Superoxide and hnRNP K. PLoS ONE. 7(2). e32349–e32349. 33 indexed citations
13.
Itagaki, S, et al.. (2012). Electrophysiological Characterization of the Polyspecific Organic Cation Transporter Plasma Membrane Monoamine Transporter. Drug Metabolism and Disposition. 40(6). 1138–1143. 26 indexed citations
14.
Zhou, Mingyan, Hongwei Liu, Adith Venkiteshwaran, et al.. (2010). High throughput discovery of new fouling-resistant surfaces. Journal of Materials Chemistry. 21(3). 693–704. 56 indexed citations
15.
Chen, Guangliang, Mingyan Zhou, Shihua Chen, Guohua Lv, & Juming Yao. (2009). Nanolayer biofilm coated on magnetic nanoparticles by using a dielectric barrier discharge glow plasma fluidized bed for immobilizing an antimicrobial peptide. Nanotechnology. 20(46). 465706–465706. 31 indexed citations
16.
Govindarajan, Rajgopal, Gph Leung, Mingyan Zhou, et al.. (2009). Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3. American Journal of Physiology-Gastrointestinal and Liver Physiology. 296(4). G910–G922. 116 indexed citations
18.
Zhou, Mingyan, Xia Li, & Joanne Wang. (2007). Metformin Transport by a Newly Cloned Proton-Stimulated Organic Cation Transporter (Plasma Membrane Monoamine Transporter) Expressed in Human Intestine. Drug Metabolism and Disposition. 35(10). 1956–1962. 200 indexed citations
19.
Zhou, Mingyan, Karen Engel, & Joanne Wang. (2006). Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain. Biochemical Pharmacology. 73(1). 147–154. 57 indexed citations
20.
Engel, Karen, Mingyan Zhou, & Joanne Wang. (2004). Identification and Characterization of a Novel Monoamine Transporter in the Human Brain. Journal of Biological Chemistry. 279(48). 50042–50049. 215 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026